 Under the initial agreement, which the court ruled against, Purdue Pharma would have emerged from bankruptcy as a different entity, with its profits used for treatment and prevention. The 5-4 decision weakens the ability of corporations and insiders to use bankruptcy to try to avoid mass litigation. The Justice Department is bringing charges against nearly 200 people for their roles in health care fraud schemes. The department says the alleged schemes involved some $1.6 billion in losses.